Varicocele (Investigational Adjunct)
Highly investigational adjunct in symptomatic varicocele; case reports only; embolization or surgical ligation remain primary for fertility or pain indications.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for varicocele. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational with case reports only.
- What evidence exists?
- Tier C (investigational). Only isolated case reports describe symptomatic scrotal pain reduction after inguinal-region hirudotherapy. There are no controlled trials, and fertility outcomes have not been studied. Per AUA/ASRM 2014 guidance, varicocele is managed conservatively if asymptomatic. Intervention — microsurgical varicocelectomy or percutaneous embolization — is indicated for symptomatic pain, infertility with abnormal semen parameters and palpable varicocele, or adolescent testicular volume discrepancy. Varicocele is fundamentally a venous-anatomy problem (testicular vein incompetence) that peripheral leech application cannot correct.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment
- Bruising and tenderness in the inguinal region for 5 to 10 days
- Aeromonas infection in a region anatomically close to the scrotum and inguinal ring
- Allergic reaction to leech saliva
- Worsening of varicocele-related pain or new inflammation
- Substantial bleeding and infection risk if a practitioner inappropriately places a leech on the scrotum or testicle (this is absolutely contraindicated)
- Delay of evidence-based embolization or surgical ligation if these are indicated
- Missed retroperitoneal pathology if right-sided varicocele has not been worked up
- Who should not consider this
- Anyone offered direct scrotal or testicular placement (this is absolutely contraindicated)
- Patients with right-sided isolated varicocele not yet worked up for retroperitoneal pathology
- Patients with infertility and a clear surgical indication
- Patients within 12 weeks of scrotal or inguinal surgery
- Patients with peripheral vascular disease, severe anemia, or on anticoagulants
- Patients with active inguinal hernia
- What to ask your clinician
- Is my varicocele left-sided, right-sided, or bilateral, and if right-sided, has retroperitoneal pathology been excluded?
- What is my semen analysis if fertility is a concern?
- Have I been offered or considered microsurgical varicocelectomy or percutaneous embolization?
- Where exactly will the leech be placed — confirm inguinal region only, not the scrotum?
- What is the realistic expected benefit, given varicocele is a venous-anatomy problem?
- What is the practitioner's experience and Aeromonas-prevention plan?
- When to seek urgent care
- Sudden severe scrotal or testicular pain (rule out torsion)
- Scrotal swelling, redness, or fever
- Fever above 38.0 C / 100.4 F or chills
- Visible blood in urine or semen
- Bleeding from a bite site lasting more than 24 hours
- Spreading redness, warmth, pus, or red streaks at any bite site
What this does NOT mean
- It does not correct the underlying testicular vein incompetence; embolization or surgical ligation does.
- It is not appropriate for fertility indications with abnormal semen parameters; that requires evidence-based intervention.
- It is not placed on the scrotum or testicle.
- Only case reports exist; benefit beyond placebo is unestablished.
Safety cross-references
Clinical Profile
- Category
- urogenital
- ICD-10
- I86.1
- Safety tier
- high
Evidence Summary
Varicocele (left-sided in ~90%) is managed conservatively if asymptomatic; intervention (microsurgical varicocelectomy or percutaneous embolization) is indicated for symptomatic pain, for infertility with abnormal semen parameters and a palpable varicocele, or for adolescent testicular volume discrepancy per AUA/ASRM 2014 guidance. No controlled clinical trial of leech therapy for varicocele has been published; use is investigational and mechanistic only, and the honest evidence grade is D. Varicocele is fundamentally a venous-anatomy problem (testicular vein incompetence) that peripheral leech application cannot correct, any venous-decongestion rationale is theoretical, application is never scrotal, and infertility outcomes have not been studied.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Khandelwal R et al. (2018)0
Detailed Trial Entries
1 trial indexed in the ASH RCT Library with full Study Profile, GRADE rating, and clinical implications:
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Active deep vein thrombosis (acute phase <2 weeks)
- Critical limb ischemia (ABI <0.4)
- Right-sided isolated varicocele (workup for retroperitoneal pathology)
- Infertility with surgical indication
- Any direct scrotal or testicular placement
- Recent scrotal/inguinal surgery
Related Conditions
Peyronie's Disease (Stable Phase)
Investigational use for stable-phase Peyronie's disease; case-report-level evidence only. Standard treatments (verapamil, collagenase, surgery) remain first-line.
Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
Investigational use for category III CP/CPPS; small case series suggest symptom reduction. Multimodal therapy remains standard.
Chronic Prostatitis / Chronic Pelvic Pain Syndrome (Extended Protocol)
Investigational extended-protocol adjunct for NIH Category III chronic prostatitis/CPPS; small case series only; UPOINT-directed therapy remains primary.
Interstitial Cystitis / Bladder Pain Syndrome (Investigational)
Highly investigational adjunct for IC/BPS refractory to conventional therapy; case reports only; AUA-guideline stepwise therapy remains primary.